rfhg_20580.1

Basic information about the TSS

---

TSS ID: rfhg_20580.1 Species: human Chr: chr1		Start: 226390523 End: 226390523 Strand: -
Source datasets	DBTSS
Protocol	TSS-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF401218:27 GeneID: 142 HGNC/MGI_ID: HGNC:270 UniProt_ID: Q96P95 Nearer transcript ids and distances:

Gene_name: poly(ADP-ribose) polymerase 1 Gene_symbol: PARP1 Gene_synonyms: ARTD1 PARP PARS Poly-PARP Gene_source: HGNC:270

TATA-Box annotation

---

Distance to TSS:	17570
Nearest PromoterID:	NM_001618
Entrez ID:	142
Nearest Unigene:	Hs.177766
Nearest Refseq:	NM_001618
Nearest Ensembl:	ENSG00000143799
Gene Name:	poly(ADP-ribose) polymerase 1
Gene Alias:	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PARP1 p2@PARP1 p3@PARP1 p4@PARP1
Sample		p1@PARP1	p2@PARP1	p3@PARP1	p4@PARP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	125.26	6.04	0.78	2.92
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	121.19	4.45	1.42	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	139.66	4.24	1.16	5.21
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	92.10	2.08	0.42	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	113.83	4.72	0.67	4.05
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	115.90	4.07	0.78	3.88
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	149.25	6.75	1.09	5.23
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	119.17	4.36	0.48	6.30
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	140.20	6.20	1.28	5.77
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	44.05	3.48	0.00	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.04	2.43	0.40	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	56.10	4.07	0.41	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.41	0.64	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.87	0.30	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	1.10	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.30	0.50	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.58	0.87	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.73	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.83	0.15	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.96	0.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.53	0.52	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.47	0.39	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.95	0.24	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.80	1.03	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.81	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.14	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.08	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.41	0.54	0.36	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.10	0.42	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.75	0.20	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.86	0.63	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.72	0.49	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	0.19	0.75	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	0.77	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.22	0.20	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	0.81	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.99	0.54	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.04	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.18	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.54	0.44	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.44	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.84	0.35	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.05	0.60	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.24	0.70	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.44	1.20	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.73	0.00	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.10	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.33	0.61	0.40	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	13.32	1.02	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.67	0.67	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.60	0.00	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	29.36	0.84	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	21.13	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.70	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.03	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.46	0.63	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.41	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.14	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.61	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.04	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.24	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.97	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.40	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	8.71	0.48	0.48	0.63
Adipocyte - breast, donor2	11327-117E4	19.09	0.80	0.32	0.48
Adipocyte - omental, donor1	11473-119C6	10.56	0.13	0.25	0.51
Adipocyte - omental, donor2	11474-119C7	11.21	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	7.70	0.67	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	7.66	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.98	0.70	0.17	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	35.79	0.20	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	26.25	0.51	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.94	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	39.73	0.88	0.48	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	29.05	0.97	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	18.72	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	0.00	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	24.54	0.00	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	14.61	0.61	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	37.13	0.44	0.44	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	11.83	0.36	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	37.42	1.44	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.13	1.03	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	34.79	1.14	0.46	1.03
Anulus Pulposus Cell, donor2	11463-119B5	21.55	0.49	0.24	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.19	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	0.00	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	0.32	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	0.75	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.46	0.49	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.44	0.30	0.45	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.68	0.00	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.79	0.19	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.63	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.78	0.00	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.04	0.00	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.18	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.83	0.00	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.54	0.21	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	0.52	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.15	0.32	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.85	0.00	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.19	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.28	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	0.43	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.24	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.41	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.92	0.17	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.79	0.23	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.37	0.76	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.52	0.83	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.02	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.64	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.87	0.67	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.92	0.00	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.63	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	72.95	0.98	1.47	0.86
Astrocyte - cerebellum, donor2	11580-120F5	35.43	0.68	0.86	1.37
Astrocyte - cerebellum, donor3	11661-122F5	28.32	1.05	0.84	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	101.44	5.58	1.39	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	128.93	3.40	0.97	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	102.17	2.39	0.60	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	195.42	5.73	1.83	4.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	193.18	8.39	1.63	5.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	186.17	5.35	1.14	4.44
Basophils, donor1	12241-129G9	21.45	0.78	0.78	0.00
Basophils, donor2	12242-129H1	33.55	0.00	1.80	0.72
Basophils, donor3	12243-129H2	13.96	0.29	1.03	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	0.43	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	1.26	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	24.54	1.04	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	10.36	0.00	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	18.53	0.90	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	249.39	15.46	13.81	14.94
Burkitt's lymphoma cell line:RAJI	10476-106I8	216.13	13.97	10.48	12.34
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	105.85	3.52	2.56	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.22	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	14.85	0.00	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	16.03	0.66	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	55.48	0.57	1.13	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.01	1.14	3.41	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	53.91	2.30	1.64	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	6.22	0.43	0.14	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	3.92	0.30	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	9.48	0.47	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.68	0.00	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.42	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.23	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.79	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.50	0.53	0.18	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.62	0.44	0.87	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	0.53	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.31	0.30	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.79	0.20	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.75	0.62	0.62	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	0.46	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.30	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.22	0.54	0.81	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.10	0.52	0.70	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	22.30	0.84	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	0.18	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.76	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.32	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.50	0.00	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.03	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.55	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	25.28	0.65	0.44	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	25.87	0.92	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	22.09	0.00	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	23.67	0.31	0.31	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	20.96	0.52	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	32.55	0.67	0.67	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	27.56	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	27.88	0.88	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	30.74	1.05	0.21	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	113.81	10.16	8.13	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	113.90	4.07	6.10	8.14
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	110.81	3.11	8.28	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	100.21	6.40	10.66	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	145.27	10.19	8.58	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	130.56	4.91	7.02	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	3.92	14.90	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	162.15	5.27	9.23	6.59
CD19+ B Cells, donor1	11544-120B5	92.87	4.11	11.51	2.47
CD19+ B Cells, donor2	11624-122B4	61.66	0.73	5.08	1.45
CD19+ B Cells, donor3	11705-123B4	60.07	2.02	1.51	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	81.22	6.46	0.40	4.44
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	47.54	3.99	0.80	4.79
CD34+ Progenitors, donor1	11545-120B6	36.15	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	26.40	0.56	0.56	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	119.11	6.76	3.76	6.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	122.21	5.41	5.41	4.06
CD4+ T Cells, donor1	11225-116C1	52.84	0.71	2.86	0.71
CD4+ T Cells, donor2	11306-117C1	44.09	0.61	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	49.41	2.13	1.83	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	64.57	1.02	1.28	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	70.30	2.70	3.59	3.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	66.98	2.87	1.72	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	46.94	0.95	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.10	4.21	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	60.55	1.88	4.34	2.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	66.94	1.86	4.74	2.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	56.42	2.58	2.26	2.74
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.66	1.34	1.34	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	65.68	1.75	2.80	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	91.08	2.64	3.52	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	55.66	0.42	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.67	2.08	3.95	2.91
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.76	0.67	1.67	3.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.35	2.18	1.09	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.07	2.14	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	60.97	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	86.59	1.67	4.45	4.26
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.44	2.82	10.40	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	67.46	3.15	5.04	2.10
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.58	1.01	3.03	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	66.72	1.73	2.17	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	77.14	1.74	3.05	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	91.06	1.98	5.44	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	80.32	5.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	87.94	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	89.45	1.66	2.77	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	106.01	2.70	3.68	2.21
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	92.40	4.62	4.62	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	84.16	2.51	2.51	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	85.87	2.77	4.15	5.54
CD8+ T Cells, donor1	11226-116C2	45.51	0.33	1.64	0.00
CD8+ T Cells, donor2	11307-117C2	42.80	0.38	1.13	1.13
CD8+ T Cells, donor3	11383-118B6	48.73	0.25	1.51	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	60.10	3.21	1.15	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	54.64	2.88	0.96	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	47.33	3.83	0.00	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	68.45	3.30	2.10	2.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	54.48	1.68	1.44	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.75	2.50	1.36	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	66.71	2.82	0.87	3.48
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	64.75	1.32	0.26	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	63.32	2.35	0.94	2.58
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	71.24	3.32	2.72	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	59.26	2.61	2.32	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	69.81	2.13	2.40	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	42.02	0.44	0.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	52.83	0.46	0.91	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.06	2.98	0.75	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.14	2.16	2.52	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	53.52	0.86	1.44	2.59
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	44.08	2.12	0.71	2.59
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	70.04	1.58	0.63	3.49
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	69.82	2.46	1.54	3.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	60.27	1.28	0.96	3.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	74.20	2.68	0.76	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	58.72	1.97	0.79	3.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	51.44	2.27	2.27	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	52.19	2.41	2.41	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	49.66	0.70	0.00	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	54.09	1.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	32.90	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	32.12	1.98	1.98	0.99
Cardiac Myocyte, donor3	11686-122I3	27.36	0.53	0.74	0.63
Chondrocyte - de diff, donor1	11261-116G1	23.23	1.04	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	8.88	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.18	0.68	0.57	0.68
Chondrocyte - re diff, donor2	11339-117F7	26.86	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	14.15	0.40	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	80.10	2.52	0.80	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	47.03	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	50.89	1.42	0.62	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	59.42	2.75	2.38	3.85
Corneal Epithelial Cells, donor1	11526-119I5	15.15	0.00	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	18.20	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	27.86	0.77	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.56	2.31	2.64	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.65	1.58	1.89	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	17.25	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.21	1.30	1.62	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.73	0.34	0.34	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.21	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	50.33	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	44.19	1.17	0.33	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	23.47	1.17	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	43.55	0.57	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	29.49	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	22.69	0.58	0.29	0.87
Endothelial Cells - Artery, donor2	11341-117F9	44.47	0.71	0.94	1.65
Endothelial Cells - Artery, donor3	11413-118E9	36.81	2.10	0.18	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.17	0.89	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.64	0.61	0.00	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	0.85	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	22.29	0.59	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	22.69	1.13	0.43	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	74.02	1.20	0.80	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	120.77	2.48	1.62	2.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	110.80	1.96	1.09	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	135.81	3.30	1.10	1.10
Endothelial Cells - Vein, donor1	11267-116G7	26.16	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	30.04	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	48.04	0.94	0.47	0.47
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.08	0.41	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.58	0.11	0.00	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.70	0.33	0.00	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.44	0.85	0.73	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.79	0.82	0.27	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.88	1.05	0.11	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.13	0.79	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.22	1.00	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	22.23	0.45	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	14.40	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.99	0.32	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	31.22	0.91	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	28.68	0.89	0.00	0.63
Fibroblast - Cardiac, donor6	11460-119B2	41.99	0.91	0.30	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	46.90	0.80	0.67	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.02	0.00	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	35.29	0.92	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	37.48	0.68	1.19	1.19
Fibroblast - Dermal, donor1	11269-116G9	28.17	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	45.28	2.36	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	28.29	0.85	0.12	0.36
Fibroblast - Dermal, donor4	11450-119A1	78.57	1.13	0.34	0.57
Fibroblast - Dermal, donor5	11454-119A5	79.55	1.40	0.70	1.92
Fibroblast - Dermal, donor6	11458-119A9	93.56	1.95	0.65	1.30
Fibroblast - Gingival, donor1	11237-116D4	41.85	1.04	0.42	2.50
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.99	1.05	0.52	1.57
Fibroblast - Gingival, donor2	11318-117D4	74.99	1.05	0.13	0.92
Fibroblast - Gingival, donor3	11394-118C8	32.20	1.06	0.48	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.97	0.35	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.86	1.56	0.47	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.89	1.35	0.27	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.30	0.88	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	42.95	1.50	0.27	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.12	2.41	0.22	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.98	0.15	0.44	0.73
Fibroblast - Lung, donor1	11270-116H1	21.75	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	47.75	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	53.39	1.90	0.42	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	0.00	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	0.00	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	84.04	2.84	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	94.27	1.94	0.39	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	133.33	1.67	0.15	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.26	1.84	0.31	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	1.91	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.92	0.81	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.79	0.35	0.35	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	39.57	1.33	0.22	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.70	2.03	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	46.11	0.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	27.68	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	41.48	1.79	1.39	1.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.23	0.71	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.62	0.59	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	37.31	0.90	1.20	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	39.19	1.62	0.43	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.80	0.00	1.77	1.27
Fibroblast - skin normal, donor1	11553-120C5	16.74	0.33	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.12	2.01	1.00	1.80
Fibroblast - skin normal, donor2	11561-120D4	31.65	0.70	0.40	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	45.64	0.91	1.81	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.36	0.58	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	39.49	1.20	0.85	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.98	0.33	1.97	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.30	0.53	0.53	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	44.70	1.69	0.51	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.53	0.00	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	310.24	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	26.52	0.69	0.52	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	44.50	1.56	0.78	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.65	0.51	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	131.67	3.06	0.00	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	141.65	7.02	0.00	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	218.51	6.28	0.86	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	118.58	3.31	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	79.46	3.20	1.37	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	158.11	2.97	0.00	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	106.53	1.32	0.26	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	87.73	4.24	0.98	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	173.79	2.21	0.88	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	214.53	3.67	0.28	1.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	170.31	5.30	0.74	3.45
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	164.94	3.76	0.81	2.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	96.76	1.86	0.50	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	119.32	1.80	0.42	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	90.06	1.83	0.00	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	79.41	2.28	0.68	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	93.30	2.24	0.62	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	83.71	3.06	0.44	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	81.85	2.95	0.30	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	124.15	3.02	1.11	2.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	92.27	1.56	0.67	2.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	103.03	3.63	1.01	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	146.23	2.88	0.34	3.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	129.73	4.34	0.80	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	110.40	2.60	0.83	1.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	89.49	2.39	0.51	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	121.17	2.66	0.55	2.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	121.63	4.58	0.92	2.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	112.30	4.90	0.82	3.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	90.16	1.86	0.41	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	106.42	1.84	0.46	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	86.72	2.67	0.83	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	69.44	1.10	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	103.19	1.97	0.98	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	90.12	2.27	0.81	3.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	74.09	1.92	1.28	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	92.20	2.08	0.95	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	88.89	0.79	1.27	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	67.20	2.74	1.22	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	84.68	2.72	0.52	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	83.21	2.42	1.10	3.73
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	66.49	1.96	0.84	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	69.26	1.94	1.30	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	66.05	1.34	0.80	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	56.31	1.53	1.22	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	76.04	1.42	0.39	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	85.39	4.07	1.36	3.52
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.80	2.03	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	48.25	1.97	1.10	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	111.08	1.98	1.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	45.77	1.98	0.26	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.98	1.01	0.40	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	62.27	1.78	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	298.59	7.17	2.19	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	228.50	5.08	1.54	2.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	350.25	7.36	2.05	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	156.47	5.32	0.31	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	129.13	3.11	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	189.09	5.07	1.84	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	136.11	4.95	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	149.31	5.03	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	86.64	4.81	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	147.80	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	98.95	3.91	1.95	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	137.13	5.77	0.41	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	95.64	5.31	0.84	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	104.92	3.27	1.96	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	104.85	2.52	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	121.82	4.45	0.64	4.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	106.65	3.06	1.36	2.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	81.44	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	121.41	3.44	0.57	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	89.09	3.26	0.89	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	98.26	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	118.88	4.56	4.14	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	121.05	2.76	2.76	4.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	79.57	3.84	1.15	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	64.54	2.28	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	48.16	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	102.87	2.31	0.39	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	79.77	2.05	1.03	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	109.33	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	84.93	1.42	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	80.26	1.81	1.81	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	80.88	2.03	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	93.73	2.79	1.20	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.50	1.97	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	74.37	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.93	1.17	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	69.51	3.39	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	62.68	1.19	1.79	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	64.54	3.40	0.97	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.38	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.18	0.32	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	95.73	1.28	1.39	4.53
Hep-2 cells mock treated, biol_rep2	11899-125E9	110.23	3.71	0.51	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	106.02	4.32	1.37	2.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	98.16	3.17	0.33	4.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	105.09	3.65	1.50	4.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	110.44	4.52	0.86	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	84.81	3.61	0.25	3.61
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	76.51	3.77	0.34	3.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	74.65	2.56	0.32	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	46.45	1.68	1.68	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.18	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.27	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.07	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	42.49	0.70	0.52	0.52
Hepatocyte, donor1	11523-119I2	53.27	1.21	1.21	1.21
Hepatocyte, donor2	11603-120I1	113.12	5.39	0.00	2.15
Hepatocyte, donor3	11684-122I1	41.72	2.45	0.61	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	75.71	1.96	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	74.63	4.37	0.87	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.42	0.69	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	3.18	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	49.84	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	2.50	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	43.86	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	3.33	0.00	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	5.29	0.00	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	46.56	1.11	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	44.72	1.89	0.00	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	41.76	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	45.22	3.23	0.65	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	54.60	4.89	0.81	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	47.44	2.94	0.42	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.02	0.00	0.00	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	49.86	4.62	0.92	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	59.48	3.30	0.94	3.78
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	40.81	1.81	0.91	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	5.38	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.28	2.55	0.64	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	56.50	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	2.14	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	3.32	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	62.66	4.94	0.31	4.63
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	1.76	1.76	8.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	56.58	3.14	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	50.76	5.56	3.48	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	1.74	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	1.07	0.00	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	0.00	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	48.78	1.84	1.84	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	25.38	1.06	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	16.65	0.24	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	9.37	1.17	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	49.41	0.57	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	77.53	1.70	1.36	1.02
Keratocytes, donor1	11527-119I6	29.57	1.72	0.00	1.38
Keratocytes, donor2	11607-120I5	32.81	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	31.42	0.99	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	169.24	0.00	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	24.81	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	68.05	1.38	1.96	1.85
Lens Epithelial Cells, donor3	11690-122I7	27.35	1.01	0.40	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.93	2.96	1.78	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	55.81	1.95	0.28	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	75.72	2.99	2.20	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	47.86	2.15	2.15	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.96	1.89	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	55.85	2.80	0.65	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.20	2.46	2.05	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.68	2.02	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	58.69	1.55	1.41	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.31	1.58	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	45.37	2.52	1.16	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	39.25	0.74	0.74	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.07	0.35	1.05	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	50.09	1.43	1.43	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	54.12	2.61	0.82	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.42	0.92	0.92	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	38.97	1.25	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	68.26	2.56	1.46	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	40.15	0.99	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	40.71	1.76	0.88	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	54.76	1.99	1.49	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	48.98	0.97	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	39.86	1.89	0.81	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	56.01	2.88	1.67	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	30.59	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.37	1.47	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.63	3.01	1.65	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.38	1.69	0.75	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	55.56	1.48	1.17	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.28	2.42	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	30.10	0.99	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	51.54	1.86	0.50	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.72	0.37	1.48	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.85	1.48	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	48.26	1.10	1.10	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.31	1.61	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	34.39	1.83	0.91	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	59.49	2.24	1.54	1.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.60	2.13	1.42	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.66	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	45.44	1.40	1.09	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.61	0.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	48.50	1.41	1.65	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	54.95	1.73	1.49	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.10	1.28	1.28	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	48.63	2.39	2.09	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	24.55	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.85	1.27	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	22.16	0.52	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.10	0.68	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	33.45	1.16	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.96	0.45	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.74	0.54	0.68	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.24	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.35	1.76	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.99	0.00	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.39	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	1.60	1.33	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.47	0.38	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.02	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	33.32	0.62	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	34.47	1.40	0.84	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	27.82	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	32.80	0.58	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	30.19	0.90	0.60	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.34	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.04	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.55	0.00	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	1.15	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.56	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.61	0.57	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	0.82	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	0.45	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	0.72	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	39.59	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.21	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.28	1.29	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.99	1.33	0.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.36	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	21.33	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.87	0.34	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	1.61	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.18	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.00	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.81	0.40	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	0.99	0.99	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.63	1.01	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.02	1.35	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.16	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	1.17	0.78	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	1.98	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.72	0.52	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	29.75	0.44	1.75	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.16	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	20.76	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.84	0.00	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	19.71	0.96	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.25	0.80	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.42	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.93	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	0.32	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.72	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	0.51	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	1.41	0.00	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.70	0.00	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.05	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.88	1.25	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.51	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.99	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.86	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	18.67	0.89	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	1.14	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.60	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.15	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.70	1.04	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	43.30	0.91	0.68	1.37
Macrophage - monocyte derived, donor2	11313-117C8	22.20	0.37	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	42.73	1.44	0.66	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	30.74	0.48	0.48	0.79
Mallassez-derived cells, donor3	11930-125I4	40.58	0.97	0.56	1.25
Mammary Epithelial Cell, donor1	11273-116H4	28.80	1.10	0.60	1.00
Mammary Epithelial Cell, donor2	11350-117G9	30.69	1.16	0.87	0.58
Mammary Epithelial Cell, donor3	11422-118F9	30.93	0.25	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	75.93	4.75	3.39	4.75
Mast cell, donor1	11563-120D6	78.19	1.73	3.89	2.16
Mast cell, donor2	11565-120D8	82.91	0.59	1.49	1.49
Mast cell, donor3	11566-120D9	92.98	2.03	1.80	2.25
Mast cell, donor4	11567-120E1	65.60	2.30	1.06	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	51.45	1.66	1.22	2.22
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	68.26	1.84	0.34	1.61
Mast cell, expanded, donor8	11941-126A6	57.57	2.18	7.70	1.67
Melanocyte - dark, donor1	11502-119F8	57.31	1.69	1.09	0.30
Melanocyte - dark, donor2	11582-120F7	38.07	1.04	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	136.91	4.42	4.13	3.11
Melanocyte - light, donor1	11274-116H5	27.03	0.47	0.47	0.24
Melanocyte - light, donor2	11351-117H1	28.66	0.68	1.36	1.36
Melanocyte - light, donor3	11423-118G1	19.95	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	88.82	1.46	0.83	1.15
Melanocyte, donor2 (MC+2)	12739-135I3	44.11	1.34	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	43.39	0.80	0.54	1.07
Meningeal Cells, donor1	11493-119E8	109.42	2.73	0.99	1.98
Meningeal Cells, donor2	11573-120E7	88.91	2.20	2.64	1.32
Meningeal Cells, donor3	11654-122E7	81.99	2.12	0.24	1.06
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	48.76	0.57	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.67	0.30	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.03	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.98	0.21	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.62	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.48	2.20	0.88	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.26	2.19	0.73	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	35.40	0.61	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.96	0.55	0.28	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.27	0.37	1.49	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.66	0.26	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	0.00	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	43.55	2.56	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	53.88	1.42	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.70	0.63	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	43.54	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	21.21	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	16.52	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	18.50	0.14	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	54.01	6.75	2.70	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	37.93	1.97	0.99	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.03	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.99	0.62	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.37	0.83	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	31.78	1.00	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	36.31	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.72	1.22	0.41	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.17	1.19	0.00	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.52	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	32.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.71	0.00	0.85	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.57	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.82	0.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.10	0.71	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.90	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.41	1.15	0.23	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.35	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.10	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	21.24	0.43	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.67	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.46	0.66	1.31	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.38	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.93	0.27	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.70	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	20.72	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.83	0.68	0.34	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.63	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.12	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.27	0.28	0.84	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.79	1.25	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	20.40	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.99	0.30	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	0.42	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	1.14	1.14	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.90	0.28	0.83	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.55	1.30	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.88	1.07	0.80	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	19.16	0.90	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.24	0.85	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	0.32	0.00	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	23.22	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.20	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	0.00	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.19	0.74	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	17.60	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.29	0.29	0.29	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.43	0.86	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	1.24	1.24	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.57	1.49	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.86	0.66	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.01	0.40	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	21.42	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	28.16	1.13	0.38	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.31	0.27	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.25	1.24	0.79	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	26.02	0.37	1.10	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.36	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	1.57	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	45.06	0.95	1.14	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	114.90	1.60	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	101.07	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.45	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.11	0.27	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.48	1.26	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	278.37	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.86	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.94	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.70	0.36	0.73	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	0.16	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.69	0.53	0.35	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.83	0.69	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	126.42	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.85	0.45	0.22	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.53	0.24	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.58	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	252.78	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.35	0.45	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	16.65	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	26.23	1.36	0.45	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.20	0.00	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.23	0.66	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.78	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	22.86	0.37	0.37	0.99
Myoblast, donor2	11322-117D8	31.84	0.58	0.77	0.58
Myoblast, donor3	11398-118D3	40.36	0.50	1.85	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	76.18	1.90	0.88	1.90
Natural Killer Cells, donor1	11230-116C6	47.97	1.85	1.85	0.62
Natural Killer Cells, donor2	11311-117C6	41.01	0.30	1.51	0.90
Natural Killer Cells, donor3	11387-118C1	37.55	0.37	1.10	0.37
Neural stem cells, donor1	11275-116H6	124.49	7.62	1.45	7.62
Neural stem cells, donor2	11352-117H2	169.46	7.70	3.85	3.85
Neurons, donor1	11494-119E9	87.62	7.97	2.28	4.55
Neurons, donor2	11574-120E8	97.09	4.18	0.88	3.74
Neurons, donor3	11655-122E8	72.35	3.29	0.82	1.64
Neutrophils, donor1	11233-116C9	5.57	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	9.77	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	39.66	1.19	1.42	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	16.61	0.65	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	19.65	0.40	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	10.74	0.14	0.69	0.55
Olfactory epithelial cells, donor2	11934-125I8	17.22	0.43	0.43	0.43
Olfactory epithelial cells, donor3	11935-125I9	15.55	0.68	0.68	0.11
Olfactory epithelial cells, donor4	11936-126A1	23.67	0.49	0.29	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	54.16	3.61	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	14.25	0.21	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	5.72	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.21	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	26.77	0.98	0.20	0.39
Osteoblast, donor2	11354-117H4	36.52	2.11	0.00	1.40
Osteoblast, donor3	11426-118G4	27.02	0.36	0.36	0.89
Pancreatic stromal cells, donor1	11249-116E7	47.51	0.51	0.25	0.84
Pericytes, donor1	11491-119E6	24.48	0.89	0.67	0.45
Pericytes, donor2	11571-120E5	20.15	0.23	0.45	0.23
Pericytes, donor3	11652-122E5	23.60	0.61	0.20	0.20
Perineurial Cells, donor1	11499-119F5	45.55	0.57	0.23	0.23
Perineurial Cells, donor2	11579-120F4	52.54	0.92	0.92	1.20
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.22	1.27	0.96	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.93	0.73	0.24	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	43.10	0.91	0.65	0.26
Placental Epithelial Cells, donor1	11278-116H9	17.22	0.48	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	19.96	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	27.09	0.79	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.80	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	8.82	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.14	0.00	0.52	0.78
Preadipocyte - breast, donor2	11328-117E5	11.71	0.23	0.23	0.90
Preadipocyte - omental, donor1	11468-119C1	11.08	0.32	0.32	0.64
Preadipocyte - omental, donor2	11329-117E6	11.78	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	10.60	0.43	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.74	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	74.02	0.89	0.71	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	23.84	0.68	0.17	0.85
Preadipocyte - visceral, donor1	11280-116I2	57.29	1.02	0.37	0.93
Preadipocyte - visceral, donor2	11357-117H7	31.29	0.92	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	37.62	0.31	0.42	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	71.35	3.77	0.30	2.41
Prostate Epithelial Cells, donor2	11331-117E8	17.20	0.68	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	6.12	0.00	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	46.02	1.59	0.11	2.05
Prostate Stromal Cells, donor2	11332-117E9	46.08	0.90	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	24.19	0.73	0.10	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	34.67	1.09	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	44.57	0.97	0.07	0.49
Renal Epithelial Cells, donor1	11517-119H5	24.35	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	41.26	0.00	0.00	2.85
Renal Epithelial Cells, donor3	11678-122H4	45.73	0.64	0.32	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	48.25	1.21	0.27	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	57.28	1.33	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	0.67	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	40.72	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	53.29	1.25	0.00	1.88
Renal Mesangial Cells, donor3	11679-122H5	18.59	0.28	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	65.23	1.61	0.00	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.74	0.42	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.42	1.16	0.39	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	62.49	1.04	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	48.61	1.71	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	0.00	1.03	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.34	1.00	0.00	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.18	1.60	0.80	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	98.27	4.47	2.68	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	110.62	4.40	4.95	7.71
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	277.27	16.82	7.54	9.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	186.07	5.72	2.34	5.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	149.95	4.37	2.68	5.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	180.02	7.70	2.79	5.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	226.63	10.17	3.23	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	168.06	6.76	2.68	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	185.83	9.48	2.08	8.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	130.20	5.61	3.15	4.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	167.01	6.50	2.72	5.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	170.77	8.78	2.87	4.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	113.47	5.59	2.30	5.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	159.15	5.69	1.82	5.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	165.29	6.20	1.33	5.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	120.25	4.40	1.91	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	174.77	5.87	1.77	6.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	185.65	9.02	3.38	9.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	145.18	5.57	2.52	7.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	182.32	8.08	2.53	6.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	164.22	7.83	2.10	6.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	121.42	4.70	2.56	4.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	151.36	9.53	5.33	5.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	171.58	5.47	2.56	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	134.01	5.65	2.73	4.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	151.82	6.25	2.21	5.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	179.18	8.19	2.82	7.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	119.82	3.54	3.30	6.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	151.98	7.54	2.98	4.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	161.12	6.08	3.51	7.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	122.55	2.28	2.28	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	172.10	6.86	3.10	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	174.84	6.89	2.92	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	137.95	5.38	3.23	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	190.73	5.96	3.07	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	170.43	7.52	2.70	7.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	126.03	6.53	2.75	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	185.18	7.00	2.47	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	190.11	6.90	2.30	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	129.70	3.92	3.41	6.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	223.71	9.32	2.96	9.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	162.60	8.80	3.20	6.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	107.99	6.36	4.15	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	160.24	6.43	3.33	6.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	170.10	5.64	4.23	9.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	97.66	4.99	4.24	4.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	129.96	6.99	3.14	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	147.48	8.16	5.14	5.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	99.01	4.77	1.47	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	153.85	9.32	4.22	8.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	124.73	8.52	4.87	10.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	95.24	4.82	3.92	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	109.25	8.37	2.94	6.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	123.71	3.59	2.70	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	90.21	5.67	2.60	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	104.16	5.34	3.20	5.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	108.78	9.01	3.61	3.00
Schwann Cells, donor1	11498-119F4	30.66	0.56	0.19	0.75
Schwann Cells, donor2	11578-120F3	37.43	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.27	0.88	0.88	0.88
Sebocyte, donor1	11220-116B5	49.85	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	27.11	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	24.53	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	28.16	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	16.95	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.56	0.70	0.18	0.79
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	47.65	1.67	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	65.35	0.63	0.16	1.10
Skeletal Muscle Cells, donor5	11455-119A6	61.24	0.74	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	82.34	1.54	0.62	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.76	1.01	0.25	1.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	48.80	1.71	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	100.40	1.09	0.20	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	60.16	1.43	0.25	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	30.40	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.04	0.28	0.83	0.28
Skin - palm, donor1	10286-104F7	29.55	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.25	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	15.54	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.85	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	14.60	0.56	0.14	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	18.71	0.56	0.14	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	50.96	2.33	0.63	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	12.37	0.60	0.07	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.41	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.34	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.24	0.22	0.00	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	0.39	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	0.77	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	2.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.58	0.13	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	0.44	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.01	0.13	0.13	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.68	0.65	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.98	1.18	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.06	0.57	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	15.94	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.61	0.30	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.69	0.76	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	42.47	0.44	0.44	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	42.40	1.29	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	50.17	0.52	0.21	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.09	0.46	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	0.00	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.83	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.07	1.02	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.14	1.26	0.39	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.17	0.30	0.40	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.29	0.23	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.26	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	126.90	3.18	0.26	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.55	0.93	0.40	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.55	0.63	0.63	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.98	0.00	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.78	0.45	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	58.15	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.14	1.40	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.40	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.32	0.29	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	95.05	1.92	0.83	2.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.63	0.93	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.54	0.43	0.14	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.75	1.02	0.51	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.31	0.56	0.19	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	57.02	0.98	0.98	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.05	0.59	0.17	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.21	0.49	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.34	0.00	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.04	1.17	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.88	0.19	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.35	0.53	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.97	0.37	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.97	0.36	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.65	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.78	0.00	0.39	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	12.38	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	1.25	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	17.88	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	11.28	0.67	0.00	0.84
Synoviocyte, donor2	11368-117I9	14.92	0.67	0.50	0.67
Synoviocyte, donor3	11440-118H9	16.76	0.00	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	77.18	1.43	1.07	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	1.98	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	33.11	0.46	0.46	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	28.75	0.36	0.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	0.39	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.33	1.35	1.60	1.60
Urethra, donor2	10319-105A4	61.15	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	9.56	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	11.22	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	9.86	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	30.09	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	0.89	3.56	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	1.43	0.00	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	0.68	1.37	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	50.96	1.03	2.07	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	53.45	0.58	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	35.40	1.04	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	52.31	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	45.64	0.91	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	92.77	1.60	1.48	1.11
Wilms' tumor cell line:HFWT	10597-108E3	38.72	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	100.83	0.84	0.56	0.56
achilles tendon, donor2	10292-104G4	16.53	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	312.32	24.99	13.00	16.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	287.90	9.52	10.68	12.77
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	94.49	4.63	3.44	5.70
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	132.25	3.54	2.45	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	272.09	8.99	3.94	8.15
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	96.86	3.17	5.50	4.23
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	103.98	3.81	6.81	4.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	111.92	3.08	0.00	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	133.94	7.35	8.17	5.72
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	154.54	8.54	1.94	4.27
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	118.31	9.02	3.31	8.28
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	117.02	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	155.23	4.65	4.42	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	143.69	5.18	1.29	6.47
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	145.54	4.68	1.75	5.55
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	106.43	3.72	1.39	5.58
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	81.84	3.70	1.23	6.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	185.70	3.99	1.23	6.14
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	244.08	5.97	1.71	6.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	245.97	10.62	2.43	7.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	265.98	10.83	3.13	11.07
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	128.74	7.35	2.45	5.35
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	112.07	4.67	0.33	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	317.75	7.43	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	154.05	5.27	1.51	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	213.27	9.59	3.49	6.98
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	258.68	16.87	11.25	0.00
adenocarcinoma cell line:IM95m	10796-110I4	65.00	2.83	0.24	2.59
adipose tissue, adult, pool1	10010-101C1	32.89	2.02	1.24	1.55
adipose, donor1	10184-103D4	194.10	4.10	0.00	1.76
adipose, donor2	10185-103D5	35.69	1.22	0.41	0.81
adipose, donor3	10186-103D6	80.05	2.45	1.91	1.36
adipose, donor4	10187-103D7	136.08	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	117.58	1.42	0.47	0.79
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	90.85	3.34	0.67	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	117.19	2.50	0.36	2.50
amniotic membrane cells, donor1	12235-129G3	34.31	0.70	0.46	1.39
amniotic membrane cells, donor2	12236-129G4	44.29	0.34	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	45.37	0.88	0.00	0.59
amygdala - adult, donor10196	10167-103B5	77.08	4.74	2.37	0.00
amygdala, adult, donor10252	10151-102I7	118.42	4.26	1.01	3.85
amygdala, newborn, donor10223	10360-105E9	34.21	1.94	0.97	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	13.37	0.64	0.38	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	193.49	12.13	4.19	10.81
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	119.92	3.34	1.00	2.00
aorta, adult, pool1	10052-101G7	26.48	0.98	0.78	1.18
appendix, adult	10189-103D9	147.48	4.27	4.66	5.82
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	118.31	5.85	0.69	4.47
artery, adult	10190-103E1	32.61	5.43	0.00	6.79
astrocytoma cell line:TM-31	10425-106D2	72.14	1.16	0.58	0.58
b cell line:RPMI1788	10427-106D4	117.33	6.39	2.97	6.39
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.16	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	82.66	2.58	0.50	2.18
bile duct carcinoma cell line:TFK-1	10496-107C1	22.60	1.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	33.00	1.68	0.56	2.24
bladder, adult, pool1	10011-101C2	57.80	2.93	1.09	1.96
blood, adult, pool1	10053-101G8	33.22	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	50.52	1.71	2.57	1.71
bone marrow, adult	10192-103E3	58.71	2.02	0.00	1.35
brain, adult, donor1	10084-102B3	59.45	3.08	3.08	1.03
brain, adult, pool1	10012-101C3	79.40	4.68	3.90	4.01
brain, fetal, pool1	10085-102B4	90.83	2.67	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.28	0.00	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	173.63	8.61	2.75	9.86
breast, adult, donor1	10080-102A8	23.99	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	72.41	2.29	0.00	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	73.29	2.16	0.00	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	39.14	1.15	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	98.05	6.29	0.24	2.42
carcinoid cell line:NCI-H1770	10703-109H1	135.88	2.35	1.41	1.41
carcinoid cell line:NCI-H727	10735-110B6	66.94	4.38	0.22	3.72
carcinoid cell line:SK-PN-DW	10719-109I8	60.21	2.22	0.63	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	197.77	3.99	0.27	3.73
caudate nucleus - adult, donor10196	10177-103C6	86.35	5.76	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	88.52	4.69	1.17	4.69
caudate nucleus, adult, donor10258	10379-105H1	36.68	6.11	0.76	3.06
caudate nucleus, newborn, donor10223	10354-105E3	43.95	2.93	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	64.09	5.83	14.57	8.74
cerebellum, adult, donor10252	10166-103B4	107.82	6.41	2.35	4.27
cerebellum, adult, pool1	10083-102B2	46.22	3.45	3.79	2.07
cerebellum, newborn, donor10223	10357-105E6	53.97	6.64	2.49	3.32
cerebral meninges, adult	10188-103D8	83.21	3.53	1.51	2.27
cerebrospinal fluid, donor2	10294-104G6	33.62	3.65	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	87.56	5.18	1.01	3.45
cervical cancer cell line:ME-180	10553-107I4	39.77	1.66	0.66	1.16
cervix, adult, pool1	10013-101C4	45.25	1.36	1.36	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.02	0.84	0.42	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	47.03	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	105.14	0.87	0.37	0.25
choriocarcinoma cell line:SCH	10785-110H2	109.41	2.96	0.49	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	70.20	0.71	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	18.80	0.57	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	33.11	0.50	0.60	0.50
chorionic membrane cells, donor3	12240-129G8	29.67	1.10	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	41.40	4.04	2.02	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	151.95	4.42	2.50	4.03
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	193.87	7.60	3.59	5.07
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	145.35	8.99	2.31	6.68
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	163.27	7.26	1.21	5.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	134.18	8.96	1.43	5.90
chronic myelogenous leukemia cell line:K562	10454-106G4	195.52	9.72	0.59	5.30
chronic myelogenous leukemia cell line:KU812	10409-106B4	219.71	7.82	3.39	8.34
clear cell carcinoma cell line:JHOC-5	10638-108I8	90.52	2.29	0.23	0.91
clear cell carcinoma cell line:TEN	10636-108I6	27.24	0.69	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	91.52	2.75	0.55	1.46
colon carcinoma cell line:COLO-320	10420-106C6	172.94	7.60	2.66	5.70
colon, adult, donor1	10082-102B1	51.17	1.19	1.19	4.76
colon, adult, pool1	10014-101C5	44.42	1.65	1.06	2.00
colon, fetal, donor1	10070-101I7	30.28	1.24	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	407.93	9.17	13.75	18.33
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	102.83	6.80	3.40	5.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	143.38	7.70	3.92	7.09
cord blood derived cell line:COBL-a untreated	10449-106F8	188.25	10.15	4.65	8.74
corpus callosum, adult, pool1	10042-101F6	152.69	14.15	4.86	11.17
cruciate ligament, donor2	10295-104G7	28.37	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	33.71	0.00	0.00	3.21
diencephalon, adult	10193-103E4	89.04	6.96	2.88	7.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	312.73	16.53	9.41	18.60
ductal cell carcinoma cell line:KLM-1	10438-106E6	102.83	3.59	0.26	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	55.13	0.96	0.24	0.24
ductus deferens, adult	10196-103E7	37.38	1.99	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	56.64	2.21	1.47	1.47
dura mater, adult, donor1	10041-101F5	52.53	0.99	0.50	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	76.17	4.66	2.00	3.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	266.53	7.88	1.29	4.44
embryonic pancreas cell line:1B2C6	10604-108F1	104.21	1.23	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	36.63	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	69.78	0.93	0.00	1.23
embryonic pancreas cell line:2C6	10603-108E9	109.02	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	124.36	5.36	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	35.34	0.54	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.76	0.64	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	99.60	2.11	0.11	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	113.51	1.76	0.77	2.53
epididymis, adult	10197-103E8	38.72	1.47	1.26	2.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.58	1.24	0.00	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.25	0.79	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	110.61	4.32	2.10	4.32
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	111.31	4.72	0.98	3.74
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	119.09	5.15	0.90	5.04
esophagus, adult, pool1	10015-101C6	40.88	1.27	0.42	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	74.01	1.00	0.00	0.50
eye - muscle inferior rectus, donor1	10272-104E2	26.56	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	80.36	1.49	1.49	4.46
eye - muscle superior, donor2	10297-104G9	51.59	3.44	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	65.58	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	47.29	2.54	2.03	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	54.62	1.03	0.00	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	48.91	0.95	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	94.29	6.66	4.79	5.91
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	109.29	2.40	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	61.35	1.01	0.18	0.64
gall bladder, adult	10198-103E9	33.80	1.45	1.93	2.17
gamma delta positive T cells, donor1	11937-126A2	71.40	1.61	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	56.77	1.12	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	47.73	1.48	1.69	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	40.81	0.77	0.19	0.97
gastric cancer cell line:AZ521	10549-107H9	123.62	2.95	0.98	1.64
gastric cancer cell line:GSS	10560-108A2	45.76	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	145.53	18.05	8.00	16.45
giant cell carcinoma cell line:LU65	10487-107B1	23.06	0.69	0.11	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	64.66	1.96	0.70	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.61	2.00	1.00	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	101.12	3.69	1.06	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	115.86	3.51	2.39	3.37
glioblastoma cell line:T98G	10485-107A8	96.47	2.65	0.33	1.55
glioma cell line:GI-1	10413-106B8	60.92	2.05	1.17	1.46
globus pallidus - adult, donor10196	10175-103C4	71.43	4.37	2.19	5.83
globus pallidus, adult, donor10252	10161-103A8	161.83	9.28	3.66	8.06
globus pallidus, adult, donor10258	10367-105F7	46.55	4.11	1.37	5.48
globus pallidus, newborn, donor10223	10364-105F4	37.84	1.60	1.60	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	428.25	12.24	2.45	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	34.56	0.64	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	180.43	6.89	0.00	1.84
hIPS +CCl2, biol_rep2	14384-156C1	161.41	5.94	1.83	1.83
hIPS +CCl2, biol_rep3	14385-156C2	181.63	5.15	1.29	1.29
hIPS, biol_rep1	14380-156B6	116.42	4.31	2.87	2.87
hIPS, biol_rep2	14381-156B7	181.75	4.80	4.12	1.37
hIPS, biol_rep3	14382-156B8	76.14	5.52	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	124.71	2.59	2.30	1.72
heart - mitral valve, adult	10205-103F7	33.48	0.90	0.90	1.49
heart - pulmonic valve, adult	10206-103F8	108.77	6.28	1.05	5.49
heart - tricuspid valve, adult	10207-103F9	39.97	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	48.36	1.22	0.41	1.84
heart, adult, diseased, donor1	10051-101G6	63.02	3.41	0.43	1.28
heart, adult, pool1	10016-101C7	72.90	3.45	0.92	2.99
heart, fetal, pool1	10046-101G1	142.73	10.17	1.44	5.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	227.13	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	126.08	3.54	0.44	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	130.48	4.49	0.73	3.52
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	134.00	3.94	0.81	3.23
hepatoma cell line:Li-7	10484-107A7	37.70	1.45	0.00	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	127.13	5.43	2.51	3.52
hippocampus - adult, donor10196	10169-103B7	68.14	2.84	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	124.91	5.51	0.61	4.49
hippocampus, adult, donor10258	10374-105G5	49.30	4.98	4.98	1.49
hippocampus, newborn, donor10223	10363-105F3	50.05	3.52	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	242.92	3.66	1.83	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	147.66	3.34	0.39	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	148.02	5.08	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	76.12	2.82	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	90.37	2.84	0.52	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	89.59	1.52	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	89.05	6.13	0.00	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	86.82	3.88	1.08	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	76.74	5.42	0.00	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	122.19	6.87	0.95	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	122.47	6.43	0.80	6.27
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	120.52	10.77	0.67	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	148.50	4.23	1.10	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	164.09	1.97	0.98	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	171.06	2.62	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	91.06	2.67	1.15	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	68.90	3.05	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	81.46	6.50	0.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.40	1.51	0.57	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	49.11	3.18	0.91	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	47.93	0.94	0.94	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	60.58	4.74	1.31	3.27
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	57.48	2.03	2.61	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	56.20	3.59	2.69	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	155.92	4.62	0.74	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	155.48	3.14	1.43	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	206.20	4.49	1.63	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	99.29	2.82	1.41	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	82.04	1.58	0.63	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	89.88	2.42	0.61	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	76.02	1.55	0.00	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.74	0.66	1.99	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	84.91	5.39	0.51	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	80.78	4.86	0.77	4.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	84.05	4.54	0.76	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	67.21	6.05	0.00	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	189.10	5.07	0.48	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	172.92	4.46	0.45	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	181.95	4.88	0.49	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	91.38	3.36	0.31	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	653.90	13.01	16.27	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	115.83	4.63	0.99	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	76.62	4.38	0.00	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	73.46	5.43	0.00	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	74.02	3.20	0.71	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	73.99	4.77	0.00	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	140.84	7.72	2.17	6.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	79.74	2.96	0.00	2.96
immature langerhans cells, donor1	11904-125F5	21.79	0.24	0.48	0.48
immature langerhans cells, donor2	11905-125F6	17.43	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	105.99	7.85	4.73	5.68
keratoacanthoma cell line:HKA-1	10791-110H8	41.62	0.65	0.33	0.98
kidney, adult, pool1	10017-101C8	37.95	1.70	1.50	1.40
kidney, fetal, pool1	10045-101F9	53.19	2.26	1.27	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.84	1.28	0.71	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	38.43	1.11	0.41	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	69.55	1.47	0.37	1.47
left atrium, adult, donor1	10079-102A7	24.52	1.09	0.54	1.09
left ventricle, adult, donor1	10078-102A6	36.91	2.02	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	98.50	1.37	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	12.21	0.72	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	13.04	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	16.51	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	73.19	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	104.95	4.84	1.42	4.13
liposarcoma cell line:KMLS-1	10782-110G8	25.62	0.00	0.00	0.78
liposarcoma cell line:SW 872	10726-110A6	77.61	2.80	1.10	2.31
liver, adult, pool1	10018-101C9	61.42	2.59	0.81	2.76
liver, fetal, pool1	10086-102B5	37.63	1.88	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	67.95	4.96	2.04	4.37
locus coeruleus, adult, donor10252	10165-103B3	107.22	7.20	1.29	4.24
locus coeruleus, adult, donor10258	10375-105G6	41.76	3.39	1.41	2.26
locus coeruleus, newborn, donor10223	10362-105F2	45.85	1.26	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	37.09	0.83	0.42	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	78.59	0.69	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	97.28	3.56	0.79	1.32
lung, adult, pool1	10019-101D1	34.97	1.42	0.71	0.71
lung, fetal, donor1	10068-101I5	57.65	1.71	2.57	2.85
lung, right lower lobe, adult, donor1	10075-102A3	27.49	2.29	0.92	0.92
lymph node, adult, donor1	10077-102A5	48.76	2.84	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	145.75	9.86	2.41	5.04
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	241.18	14.19	23.85	16.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	75.61	7.65	0.85	3.40
mature adipocyte, donor1	12231-129F8	42.62	2.22	2.66	1.33
mature adipocyte, donor2	12232-129F9	38.39	1.66	2.70	2.49
mature adipocyte, donor3	12233-129G1	32.24	1.90	1.42	2.13
mature adipocyte, donor4	12234-129G2	30.01	2.90	1.32	3.95
maxillary sinus tumor cell line:HSQ-89	10414-106B9	104.60	2.62	0.24	3.10
medial frontal gyrus - adult, donor10196	10170-103B8	71.07	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	94.16	3.86	2.76	4.05
medial frontal gyrus, adult, donor10258	10368-105F8	40.98	2.22	3.18	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	92.55	1.71	0.85	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	67.16	4.73	2.36	2.70
medial temporal gyrus, adult, donor10252	10156-103A3	121.82	6.37	2.55	3.82
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	1.93	9.63	9.63
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	660.27	28.71	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	45.94	0.72	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	60.35	4.54	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	117.50	9.44	2.01	4.80
medulla oblongata, adult, pool1	10038-101F2	114.77	8.82	3.59	5.88
medulla oblongata, newborn, donor10223	10361-105F1	54.51	2.08	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	259.49	17.49	1.55	10.63
medulloblastoma cell line:ONS-76	10759-110E3	95.98	3.30	0.86	1.71
melanoma cell line:COLO 679	10514-107E1	51.03	1.58	0.29	1.01
melanoma cell line:G-361	10465-106H6	33.66	1.36	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	24.24	0.72	0.54	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	441.46	21.15	2.64	12.34
merkel cell carcinoma cell line:MS-1	10844-111E7	276.85	14.26	2.85	10.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.52	1.07	0.31	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.63	0.18	1.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.53	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	23.74	0.28	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.87	0.77	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	1.39	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.81	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.75	0.12	0.23	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.60	0.66	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	28.36	0.54	0.14	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.10	0.85	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.26	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.94	0.42	0.42	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.29	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.68	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.14	0.21	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.80	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	57.48	0.84	0.00	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.53	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.82	0.26	0.44	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.78	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.59	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.57	2.53	0.84	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.42	0.00	0.46	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.65	0.00	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.11	0.52	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.79	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.00	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.20	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.75	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.76	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	26.53	0.29	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.06	0.67	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.27	0.00	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.44	1.01	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.33	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.37	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	10.63	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.21	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.93	0.00	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.45	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.96	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	27.54	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	20.78	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	1.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.93	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	11.53	2.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.90	0.99	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.58	0.65	0.32	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.78	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	28.35	0.47	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	91.05	1.16	0.70	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	31.65	0.51	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	34.04	1.13	0.68	0.91
mesothelioma cell line:Mero-41	10851-111F5	85.08	2.44	0.73	2.20
mesothelioma cell line:Mero-48a	10852-111F6	36.09	1.99	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	35.48	2.89	0.79	2.63
mesothelioma cell line:Mero-83	10854-111F8	54.64	2.21	0.51	0.68
mesothelioma cell line:Mero-84	10855-111F9	66.73	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	71.64	1.86	1.86	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	45.06	1.33	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	25.88	0.72	0.36	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	41.85	1.02	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	75.07	1.02	0.51	1.78
mesothelioma cell line:No36	10857-111G2	86.44	0.65	0.65	2.94
mesothelioma cell line:ONE58	10858-111G3	30.89	1.63	0.27	1.08
migratory langerhans cells, donor1	11901-125F2	44.14	2.11	0.77	1.34
migratory langerhans cells, donor2	11902-125F3	37.73	1.47	0.61	1.22
migratory langerhans cells, donor3	11903-125F4	55.28	2.69	2.15	2.69
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.73	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.76	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.62	0.69	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.08	1.14	0.57	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	112.35	7.58	0.74	7.76
myeloma cell line:PCM6	10474-106I6	70.76	5.53	1.38	4.55
myxofibrosarcoma cell line:MFH-ino	10600-108E6	149.14	5.07	2.03	4.06
myxofibrosarcoma cell line:NMFH-1	10684-109E9	41.39	2.55	0.20	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.68	0.11	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.25	0.15	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	9.94	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	207.74	19.10	0.46	15.64
neuroblastoma cell line:NB-1	10539-107G8	252.94	10.66	1.31	8.23
neuroblastoma cell line:NBsusSR	10607-108F4	62.42	5.69	1.27	5.27
neuroblastoma cell line:NH-12	10555-107I6	140.32	7.64	1.30	6.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	116.72	4.98	1.90	5.46
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	74.60	1.74	0.79	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	122.16	3.02	0.00	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	167.84	2.54	1.27	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	24.75	1.06	0.27	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	269.41	9.13	6.76	6.26
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	243.35	12.01	1.60	10.41
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	34.30	0.96	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.02	0.53	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	98.24	7.31	4.22	5.44
occipital cortex - adult, donor10196	10172-103C1	76.23	2.06	2.06	6.18
occipital cortex, adult, donor10252	10163-103B1	118.08	6.98	3.49	4.56
occipital cortex, newborn, donor10223	10355-105E4	51.32	1.46	1.09	1.09
occipital lobe, adult, donor1	10076-102A4	61.66	2.10	2.89	2.36
occipital lobe, fetal, donor1	10073-102A1	70.80	5.15	1.29	3.00
occipital pole, adult, pool1	10036-101E9	75.29	5.76	3.86	5.12
olfactory region, adult	10195-103E6	70.88	3.06	2.48	3.06
optic nerve, donor1	10277-104E7	152.08	14.01	6.00	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	59.57	2.28	1.48	3.53
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	120.90	0.96	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	40.30	0.85	0.17	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	55.44	1.62	0.46	1.73
osteoclastoma cell line:Hs 706.T	10704-109H2	15.58	0.00	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	136.41	0.93	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	68.71	1.91	0.21	1.70
ovary, adult, pool1	10020-101D2	39.31	2.27	0.61	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	46.38	1.28	0.18	0.73
pancreas, adult, donor1	10049-101G4	74.31	8.47	1.88	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.61	0.84	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	43.44	0.68	0.17	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	34.44	0.17	0.17	0.50
paracentral gyrus, adult, pool1	10035-101E8	87.86	5.86	5.03	5.22
parietal cortex, adult, donor10258	10373-105G4	55.78	5.14	2.20	2.94
parietal lobe - adult, donor10196	10171-103B9	63.01	2.82	2.82	5.64
parietal lobe, adult, donor10252	10157-103A4	85.80	2.85	2.57	4.56
parietal lobe, adult, pool1	10034-101E7	98.87	8.64	3.08	5.20
parietal lobe, fetal, donor1	10072-101I9	85.35	5.82	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	59.44	3.74	0.37	2.99
parotid gland, adult	10199-103F1	55.50	4.32	1.23	2.47
penis, adult	10200-103F2	49.95	4.83	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.80	0.19	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	46.48	0.15	0.29	0.58
pineal gland - adult, donor10196	10179-103C8	71.60	4.52	18.71	5.16
pineal gland, adult, donor10252	10160-103A7	124.36	15.99	14.81	7.11
pineal gland, adult, donor10258	10377-105G8	50.17	7.52	3.14	3.76
pituitary gland - adult, donor10196	10180-103C9	84.99	10.12	3.04	5.06
pituitary gland, adult, donor10252	10162-103A9	137.07	13.03	4.17	8.34
pituitary gland, adult, donor10258	10378-105G9	50.22	7.66	1.70	5.11
placenta, adult, pool1	10021-101D3	60.09	1.51	0.65	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	110.31	4.37	1.59	4.77
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.67	1.09	0.31	0.78
pons, adult, pool1	10033-101E6	99.24	7.66	3.27	6.54
postcentral gyrus, adult, pool1	10032-101E5	88.31	5.58	3.57	4.97
promyelocytes/myelocytes PMC, donor1	12132-128D8	192.41	6.27	2.09	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	112.60	2.33	0.44	1.31
prostate cancer cell line:PC-3	10439-106E7	221.79	4.36	0.36	3.63
prostate, adult, pool1	10022-101D4	52.42	2.45	1.45	1.54
putamen, adult, donor10196	10176-103C5	93.25	3.07	1.65	3.54
putamen, adult, donor10252	10152-102I8	64.70	0.00	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	61.20	2.19	5.46	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	67.89	1.93	1.45	2.42
putamen, newborn, donor10223	10365-105F5	59.22	3.00	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	97.75	5.24	1.16	3.78
rectum, fetal, donor1	10067-101I4	62.59	2.78	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	71.02	2.76	0.85	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.27	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	64.41	3.08	3.78	2.78
retinoblastoma cell line:Y79	10475-106I7	325.27	20.26	2.86	16.37
rhabdomyosarcoma cell line:KYM-1	10787-110H4	115.69	1.35	0.61	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	247.46	7.59	0.28	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	62.90	1.52	2.27	0.00
salivary acinar cells, donor1	11771-123I7	28.97	0.81	0.65	1.78
salivary acinar cells, donor2	11772-123I8	23.82	1.24	0.69	1.24
salivary acinar cells, donor3	11773-123I9	41.05	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	36.60	3.43	2.29	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.27	0.93	0.17	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.74	0.59	0.47	1.18
seminal vesicle, adult	10201-103F3	40.21	1.59	1.06	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.16	1.70	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.89	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	52.65	1.88	0.94	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	56.26	2.21	0.44	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	53.67	1.94	0.00	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	49.65	8.51	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	51.57	4.56	1.92	3.48
skeletal muscle, fetal, donor1	10066-101I3	50.25	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	41.03	3.16	0.63	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	141.08	2.00	1.00	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	181.87	6.62	1.26	5.04
small cell lung carcinoma cell line:DMS 144	10841-111E4	127.98	2.12	1.54	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	168.95	13.02	2.47	10.05
small cell lung carcinoma cell line:NCI-H82	10842-111E5	247.23	4.50	0.80	3.54
small cell lung carcinoma cell line:WA-hT	10562-108A4	155.59	12.64	5.01	10.90
small intestine, adult, pool1	10024-101D6	41.09	2.87	0.84	2.03
small intestine, fetal, donor1	10064-101I1	46.19	2.21	0.00	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	72.83	4.10	0.51	7.69
smooth muscle, adult, pool1	10048-101G3	68.49	5.17	0.78	3.10
somatostatinoma cell line:QGP-1	10781-110G7	74.24	2.68	1.07	3.48
spinal cord - adult, donor10196	10181-103D1	75.25	4.13	2.75	4.82
spinal cord, adult, donor10252	10159-103A6	126.56	7.10	3.15	4.34
spinal cord, adult, donor10258	10369-105F9	75.41	3.46	0.69	3.46
spinal cord, fetal, donor1	10056-101H2	85.99	5.49	2.44	2.44
spinal cord, newborn, donor10223	10359-105E8	87.71	4.59	1.38	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	26.44	0.60	0.75	0.30
spleen, adult, pool1	10025-101D7	85.46	4.41	3.52	3.30
spleen, fetal, pool1	10044-101F8	94.95	2.38	2.70	1.67
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	83.84	4.45	2.28	4.87
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	54.68	0.95	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	74.08	1.75	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	35.57	0.78	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	45.81	2.48	0.45	2.48
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	85.14	2.54	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	59.65	1.27	0.00	0.85
stomach, fetal, donor1	10062-101H8	61.94	2.14	1.07	2.14
submaxillary gland, adult	10202-103F4	45.57	0.57	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	155.78	10.18	1.87	9.55
substantia nigra, adult, donor10258	10371-105G2	63.62	3.62	3.62	3.62
substantia nigra, newborn, donor10223	10358-105E7	38.86	4.95	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	152.23	3.90	1.60	6.65
temporal lobe, adult, pool1	10031-101E4	86.30	5.85	3.56	5.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	113.25	5.70	2.85	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	90.98	2.64	0.88	4.83
tenocyte, donor1	11763-123H8	32.47	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	19.08	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	21.50	0.00	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	391.76	11.73	1.02	5.95
teratocarcinoma cell line:NCR-G1	10798-110I6	109.91	4.62	0.92	2.31
teratocarcinoma cell line:PA-1	10807-111A6	138.55	2.01	0.62	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	282.58	5.59	1.52	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	372.12	10.21	0.38	7.19
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	233.28	8.29	1.96	4.58
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	191.51	6.51	0.98	3.91
testis, adult, pool1	10026-101D8	55.40	3.44	2.25	2.79
testis, adult, pool2	10096-102C6	109.16	6.32	3.61	11.28
thalamus - adult, donor10196	10168-103B6	119.23	4.42	1.10	5.52
thalamus, adult, donor10252	10154-103A1	142.22	10.16	1.72	7.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	56.97	1.54	12.32	10.78
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.87	2.47	1.48	1.81
thalamus, newborn, donor10223	10366-105F6	42.00	1.73	0.58	0.58
throat, adult	10209-103G2	42.69	2.50	1.00	1.75
throat, fetal, donor1	10061-101H7	57.89	3.05	1.52	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	88.83	1.79	0.00	2.98
thymus, adult, pool1	10027-101D9	104.39	2.88	1.79	1.69
thymus, fetal, pool1	10043-101F7	86.14	2.08	1.66	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.59	1.20	0.53	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	63.14	0.70	0.56	0.84
thyroid, adult, pool1	10028-101E1	39.19	2.61	1.12	1.40
thyroid, fetal, donor1	10060-101H6	45.88	1.85	1.32	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	0.00	0.00	3.08
tongue, adult	10203-103F5	47.21	2.09	0.70	1.63
tongue, fetal, donor1	10059-101H5	58.33	0.79	0.79	1.18
tonsil, adult, pool1	10047-101G2	127.32	5.71	7.21	4.31
trachea, adult, pool1	10029-101E2	41.55	1.64	0.82	1.55
trachea, fetal, donor1	10058-101H4	36.55	2.31	1.15	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.78	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	102.63	3.24	1.01	2.53
transitional-cell carcinoma cell line:JMSU1	10492-107B6	105.61	2.35	0.78	2.35
tridermal teratoma cell line:HGRT	10694-109G1	106.54	1.90	3.81	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.42	1.10	0.34	1.19
umbilical cord, fetal, donor1	10057-101H3	22.95	0.00	0.00	4.17
uterus, adult, pool1	10100-102D1	57.16	2.56	1.71	2.90
uterus, fetal, donor1	10055-101H1	62.97	0.51	0.51	1.54
vagina, adult	10204-103F6	38.13	0.00	0.65	0.65
vein, adult	10191-103E2	73.65	3.51	2.63	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	87.59	2.67	2.14	2.94